Dr. Grose graduated from the University of Glasgow, UK in the year 2000. He became a Member of the Royal College for Physicians in 2003, and a Fellow of the Royal College for Radiologists in 2009. He started Post Graduate Research in 2009 which lead to his MD in 2015 from the University of Glasgow. In January 2006, he was appointed as a specialist at the Clinical Oncology Beatson Oncology Centre, UK. In January 2011, he became a Consultant Clinical Oncologist at Beatson West of Scotland Cancer Centre, UK. He chairs the North Glasgow Head & Neck MDT and is deputy lead for the West of Scotland Managed Clinical Network for Head and Neck Cancers. In addition, he is the Clinical Lead for the West of Scotland Oligo-Metastatic SABR service. Dr. Grose is experienced in Upper GI, Pancreatic, Head, and Neck Cancers management. Dr. Grose has a special interest in the field of research. He is the Clinical Chief Investigator for the upcoming PRIMUS 002 trial which aims to improve the survival rates of patients with pancreatic cancer. He is a Principal Investigator for a number of previous and ongoing trials of systemic therapy in head & neck cancers which has lead to extensive experience with novel agents including Immuno-Oncology therapy in this setting.